Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives.
about
Contraception and abortionExtended regimen combined oral contraception: A review of evolving concepts and acceptance by women and cliniciansThe lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μgThe Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept.Elements of the menstrual suppression debate.Sex-related differences in epidemiological and clinic-based headache studies.Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies.Continuous use of oral contraceptives: an overview of effects and side-effects.Evolution of extended use of the combined oral contraceptive pill.Expert opinion on a flexible extended regimen of drospirenone/ethinyl estradiol contraceptive.Advances in pharmacotherapy for treating endometriosis.Levonorgestrel intrauterine system: a first-line medical treatment for heavy menstrual bleeding.The effect of a continuous regimen of drospirenone 3 mg/ethinylestradiol 30 microg on Cox-2 and Ki-67 expression in the endometrium.Knowledge and attitudes of female university students on menstrual cycle and contraception.Gynaecological issues in adolescents with disability.Heavy menstrual bleeding diagnosis and medical management.
P2860
Q24679808-DE7D20E2-D835-4EE8-928F-84C6F1D6AC65Q28392784-96AAC544-E5F5-4175-A2E8-E291AE343EE4Q34345598-1A769407-6034-4BA9-AD12-0EF9DF3920F0Q36904113-9A52006F-D7FD-4775-B07C-EB1C068848C2Q37229306-0006EA94-8F80-469B-B183-3415ADEFEB0DQ37883445-E99C8189-6FEE-43A7-9C88-1B0BFE112EC2Q38044023-7E85B817-B215-4A3F-BFC0-A20C2C3A4422Q38053497-02052DAB-FFC6-4C56-BE26-439CDB477930Q38197591-0D9BE20A-EF83-4D96-932D-EF5D9D4808ECQ38245880-C5A6C804-31BC-4947-A7E5-9EE4F1050382Q38633773-54671288-0484-4C19-BC7E-9123638F5E43Q39878679-5B9498CF-E025-4CDF-81D5-F2F52BEC42E4Q43197782-93A502F6-B756-4A05-BD9C-CB5049E3B6C0Q47614194-17B31769-1B12-4DEC-B551-57659D8F9496Q48583350-062BBA7B-0501-4D51-B349-714EDA97A472Q54957411-B968E749-B625-4637-B3DF-4A81A7995093
P2860
Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@ast
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@en
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@nl
type
label
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@ast
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@en
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@nl
prefLabel
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@ast
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@en
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@nl
P1433
P1476
Menstrual-cycle-related sympto ...... us use of oral contraceptives.
@en
P2093
David F Archer
P304
P356
10.1016/J.CONTRACEPTION.2006.06.003
P577
2006-09-15T00:00:00Z